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Abstract.  We have developed a  method for the isola- 
tion of the subcellular organelles from bovine liver 
which are enriched in the cation-independent mannose 
6-phosphate receptor (CI-MPR) and the cation- 
dependent mannose 6-phosphate receptor (CD-MPR). 
The purification scheme consists of sedimentation of a 
postnuclear supernatant fraction on a  sucrose gradient 
followed by immunoisolation using specific 
anti-peptide antibodies conjugated to magnetic poly- 
styrene beads.  Antibodies that recognize the cytoplas- 
mic domain of either the CI-MPR or the CD-MPR 
routinely give membrane preparations that are ~50- 
fold enriched in each of the respective receptors, as 
determined by quantitative Western blotting. The im- 
munoisolated membranes are also enriched in the 
other MPR,  as well as in the asialoglycoprotein recep- 
tor. They contain significantly lower levels of enzyme 
activities representative of the plasma membrane (5' 
nucleotidase) or the Golgi complex (galactosyltransfer- 
ase and sialyltransferase). There is little or no enrich- 
ment for either the lysosomal enzymes/3-hexos- 
aminidase and tartrate-resistant acid phosphatase, or 
the mitochondrial enzyme succinate-tetrazolium reduc- 
tase.  These data, together with electron microscopy of 
the immunoisolated material, suggest that the bulk of 
MPR-containing membranes we have isolated from bo- 
vine liver correspond to endosomes. Analysis by SDS- 
PAGE indicates that several proteins, including two 
with apparent molecular weights of 170 K  and 400 K, 
are significantly enriched in the purified fractions and 
may represent potential markers for MPR-containing 
endosomes. 
M 
ANNOSE 6-phosphate  receptors  (MPRs) t  have  a 
key role in the targeting of acid hydrolases to lyso- 
somes in a variety of cell types (reviewed in refer- 
ences 37, 61). These receptors bind lysosomal enzymes bear- 
ing phosphomannosyl residues in the Golgi or on the cell 
surface, and then release these ligands when they encounter 
the  low pH  environment characteristic of newly forming 
lysosomes. Two distinct receptors have been identified (32, 
54). The cation-independent MPR (CI-MPR) and the cation- 
dependent  MPR  (CD-MPR)  are  both  integral  membrane 
glycoproteins that appear to span the membrane bilayer a sin- 
gle time (9, 39, 53, 55).  The lumenal (extracytoplasmic) do- 
mains form the bulk of the protein mass of both receptors, 
and are responsible for binding ligands. The CI-MPR and 
the  CD-MPR  have distinct amino acid sequences  (9,  39, 
45,  48),  but regions of similarity suggest the two are ho- 
mologous. The CI-MPR has a protein molecular weight of 
~270,000 and binds ligands in a cation-independent manner 
•  (39,  45,  58).  The CD-MPR is thought to be a  functional 
1. Abbreviations used in this paper: ASGP R, asialoglycoprotein receptor; 
CD, cation-dependent; CI, cation-independent; Man-6-P, mannose 6-phos- 
phate;  MPR,  mannose 6-phosphate receptor; NRK,  normal  rat  kidney; 
PNS, postnuclear supernatant; TGN, trans-Golgi network. 
homo-dimer, with each subunit having a protein molecular 
weight of ,x,30,000 (9, 48, 55).  Its affinity for lysosomal en- 
zymes is increased in the presence of divalent cations (59). 
Much of what is postulated regarding the Man-6-depen- 
dent pathway has emerged from studying the subcellular dis- 
tribution and routing of the Man-6-P receptors themselves, 
particularly the CI-MPR. It was originally postulated to be 
an endocytic receptor from studies on the cell surface bind- 
ing and uptake of lysosomal enzymes (30). It has been local- 
ized in a variety of cell types to the Golgi stacks, the trans- 
Golgi  network  (TGN;  also  called  trans-Golgi  reticulum, 
trans-tubular  network, or GERL), the plasma membrane, 
clathrin coated vesicles, and endosomes (6, 7, 8,  13, 19, 26, 
53, 65), with the bulk of the receptor found in endosomes 
at steady-state. The receptor cycles through these compart- 
ments; surface labeling experiments have shown that all of 
the CI-MPR or CD-MPR are in single pools (12,  52,  56, 
62). Neither MPR is present at a significant level in mature 
(dense)  lysosomes, and so receptor-ligand dissociation is 
thought to occur in an earlier, prelysosomal, acidic compart- 
ment (7, 21, 55). Griffiths et al. (26) have shown that most 
of the CI-MPR in normal rat kidney (NRK) cells is localized 
in a late endosomal structure that contains lysosomal pro- 
teins and receives ligands internalized at the cell surface. 
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sized lysosomal enzymes from the Golgi, and would there- 
fore represent the junction point of the biosynthetic and en- 
docytic pathways. 
The distribution of the CD-MPR has been less well-stud- 
ied than that of the CI-MPR. Preliminary immunolocalization 
experiments suggest that the CD-MPR, like the CI-MPR, is 
found in the TGN, the plasma membrane, and various endo- 
somal structures (Griffiths, G., unpublished observations). 
It is thought to be important for sorting along the biosyn- 
thetic pathway, since cell lines which lack detectable levels 
of the CI-MPR but have the CD-MPR contain nearly normal 
levels  of many lysosomal enzymes (15, 31). Furthermore, 
treatment of cells with antibodies which block the ligand 
binding site of the CD-MPR results in increased secretion of 
newly synthesized lysosomal enzymes (56).  The CI-MPR 
has a higher affinity than the CD-MPR for most Man-6-P- 
containing ligands that have been examined to date (58, 59); 
there  are  no examples of lysosomal enzymes which will 
selectively bind to the CD-MPR.  These points  suggest a 
functional redundancy for the CI-MPR and the CD-MPR. 
However, the CD-MPR has been reported to not function in 
the endocytosis of lysosomal enzymes (56), even though it 
cycles between intracellular membranes and the cell surface 
(12, 56, 62). Perhaps the two receptors are enriched in func- 
tionally (and physically) distinct populations of endosomal 
structures. It is also possible that the two receptors use sepa- 
rate prelysosomal compartments to sort lysosomal enzymes 
to different classes of lysosomes. 
Relatively little is known about the basic mechanisms gov- 
erning receptor movement; an important first step is to define 
the biochemical characteristics of the organelles involved. 
With this in mind, we have developed procedures to purify 
membranes from bovine liver which are enriched in either 
the CI-MPR or the CD-MPR.  The basic  strategy was to 
perform immunoisolation using antibodies which recognize 
unique amino acid sequences of the cytosolic domains of 
each receptor.  We have characterized the immunoisolated 
membrane preparations in an effort to: (a) establish whether 
the CI-MPR and the CD-MPR are present in the same, or 
different, populations of membranes, (b) determine the most 
likely cellular origin of these membranes, and (c) identify 
other proteins which might be enriched in these membranes 
and which could play a role in receptor movement and the 
targeting of lysosomal enzymes. 
Materials and Methods 
Materials 
Peptides corresponding to various regions of the MPRs were synthesized, 
purified, and coupled to carder proteins by Joe Bullock of Monsanto (St. 
Louis,  MO).  Dynabeads were obtained from Dynal, Inc.  (Great  Neck, 
NY). Nal25I and UDP-[3H]galactose were from Amersham Corp. (Arling- 
ton Heights, IL).  CMP-[3H]sialic acid was from American Radiolabeled 
Chemicals, Inc. (St. Louis, MO). Iodogen was from Pierce Chemical Co. 
(Rockford, IL). Molecular weight standards for SDS-PAGE and the Brad- 
ford protein reagent were from Bio-Rad Laboratories (Cambridge, MA); 
other PAGE reagents came from ICN Biochemicals (Irvine, CA). Aflinity- 
purified goat anti-rabbit IgG and all protease inhibitors were from Sigma 
Chemical Co. (St. Louis, MO). Other reagents were as noted or from stan- 
dard suppliers. 
Liver Homogenization and Density Gradient 
Centrifugation 
Fresh calf liver was obtained from a local slaughterhouse and kept on ice 
until use. A portion (15-20 g) was excised and rinsed thoroughly with sev- 
eral hundred milliliters of homogenization buffer (25  mM Pipes, pH 7.4, 
100 mM potassium chloride, 250 mM sucrose, 10 mM EDTA) containing 
a  1:500 dilution of protease inhibitor cocktail (5 mg/ml benzamidine and 
1 mg/ml each of pepstatin A, leupeptin, antipain, and chymostatin in 40% 
dimethyl sulfoxide, 60%  ethanol). The tissue was minced on ice and ho- 
mogenized in 3 vol of buffer with 10-12 strokes of a loose fitting glass/teflon 
homogenizer (Wheaton Instruments Div., Millville, NJ).  Unbroken cells 
and nuclei were removed by centrifugation at 600 g for 5 min. 60-70% of 
the total  protein was routinely  recovered in the postnuclear supernatant 
(PNS), which served as the starting material for fractionation on sucrose 
density gradients or immunoisolation. Some experiments (Fig. 4, B and C, 
and three of the six experiments summarized for Fig. 5) were performed 
using a postnuclear supernatant (PNS) fraction that had been frozen and 
thawed one time. The sucrose gradients were prepared with a standard linear 
gradient maker using 15 ml each of 15 or 45% sucrose in homogenization 
buffer containing a  1:1,000 dilution of protease inhibitor cocktail. The gra- 
dients were overlayed with "°2 ml of PNS (60-80 nag protein) and then with 
5 ml of homogenization buffer minus sucrose. The tubes were centrifuged 
in a  rotor (model SW'27; Beckman Instruments, Inc.,  Palo Alto, CA) at 
25,000  rpm (110,000 gmax) for  14-16  h  at 4°C.  Fractions were collected 
from the bottom of the tubes and the sucrose concentration determined with 
a refractometer. The protein concentrations of the initial homogenate, the 
PNS, and the sucrose gradient fractions were estimated using the method 
of Bradford (3) with BSA as standard. 
Analysis of Marker Enzymes 
/~-Hexosaminidase activity was measured in 50 mM sodium citrate, pH 4.3, 
0.2 % Triton X-100 using 1 mM 4-methylumbelliferyl-N-acetyl-/~-D  glucos- 
amide (Sigma Chemical Co.) as substrate. The reaction mixtures were in- 
cubated at 37°C,  quenched with 0.2 M sodium carbonate, and the relative 
fluorescence (excitation at 360 nm, emission at 415 nm) determined in an 
Aminco fluorometer (S. L. M. Instrument Co., Urbana, IL). The procedure 
for measuring galactosyltransferase activity was a slight modification of that 
described by Bretz and Staubli (4).  The donor substrate was UDP-D-[6- 
3H]galactose (supplemented with nonradioactive material to 0.4 mM) and 
the acceptor was N-acetylglucosamine (50 mM).  5' nucleotidase activity 
was determined according to the method described by Morre (42) using 10 
mM AMP in 50 mM Tris, pH 8.5,  l0 mM magnesium chloride,  10 mM 
sodium/potassium tartrate, and 0.2 % Triton X-100. The inorganic phosphate 
produced was measured by the method of Fiske and SubbaRow (as de- 
scribed in reference 38). Acid phosphatase activity was determined by dilu- 
tion of the samples into 100 mM sodium acetate, pH 5.0, 2 mg/ml BSA, 
0.2%  Triton X-100, 1 mM EDTA, 10 mM p-nitrophenyl phosphate (Sigma 
Chemical Co.)  and either  10  mM sodium chloride or  10  mM sodium/ 
potassium tartrate (16). The samples were incubated at 37°C, the reaction 
quenched with 0.5 M glycine, pH 10.4, and the absorbance read at 405 tun. 
The difference in activity with and without tartrate was taken as tartrate- 
inhibitable acid phosphatase activity.  Succinate-INT reductase activity was 
measured as described (46). CMP-NeuAc:glycoprotein sialyltransferase ac- 
tivity was also determined as described (5), using asialofetuin as acceptor 
(27). The incorporation of [3H]sialic acid was nearly completely dependent 
on the exogenously added substrate. 
PAGE, Immunoblotting, and Receptor Quantitation 
The conditions for PAGE in SDS were as described by Maizel (40). All sam- 
ples were denatured by boiling in SDS sample buffer containing 100 mM 
2-mercaptoethanol for 5 min. Silver staining was performed according to 
Oakley (44). For immunoblotting, the 8% polyacrylamide gels were equili- 
brated in transfer buffer (150 mM glycine, 20 mM "Iris, 20% methanol, pH 
8.3) and transferred to nitrocellulose (Schleicher &  Schuell, Inc., Keene, 
NH) in a Transblot apparatus (Bio-Rad Laboratories) at 30-35 V for 8-14 h, 
similar to the method first described by Towbin (60). Control experiments 
established that under these conditions >80% of 125I-labeled CI-MPR and 
CD-MPR added in trace amounts to 50 #g PNS protein were transferred 
to the blot (data not shown). Subsequent treatment of the nitrocellulose blot 
varied with the protein being examined. For the CI-MPR and the ASGP R, 
the blot was incubated for 2 h in blotto (5 % [wt/vol] nonfat dry milk (Carna- 
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and 0.01% antifoam [Sigma Chemical Co.]). This and all the following steps 
were performed on a  rotary shaker at room temperature. The blots were 
rinsed with fresh blotto,  and the appropriate antisera was applied.  The 
anti-CI-MPR was diluted 1:200 in blotto and the anti-ASGP R was diluted 
1:100 in blotto; each preparation was used for many blots and was stored 
at -20°C between uses. The antibodies were allowed to bind for 2 h, the 
blots were washed five to six times (5 min each) in blotto, and 1 x  107 cpm 
of '2Sl-labeled goat anti-rabbit lgG  (prepared as described below) was 
added in biotto. After a  l-h incubation, the blots were washed three times 
(10 min each) in blotto and four times (5 min each) in PBS (50 mM sodium 
phosphate, pH 7.5,  150 mM sodium chloride). The nitrocellulose was al- 
lowed to air dry, wrapped in cellophane, and put down for autoradiography 
with Kodak X-OMAT AR film. 
Various protocols were used for the CD-MPR blots; all were similar to 
that described above. The best results were obtained by washing in 1% poly- 
vinylpyrrolidone 40 (Sigma Chemical Co.) in PBS after the initial blocking 
of the nitrocellulose with blotto. The blots were then incubated in a prepara- 
tion of afftnity-purified anti-CD-MPR antibodies (see below) in this buffer 
for 4-12 h at room temperature. The washing steps were performed with 
PBS first with, and then without, 1% polyvinylpyrrolidone 40, and the 1251- 
labeled goat anti-rabbit IgG was added in 1% polyvinylpyrrolidone 40 in 
PBS. The final washes consisted of once in 1% polyvinylpyrrolidone 40 in 
PBS, once in PBS, once in 0.025%  Triton X-100  in PBS (all  for 10 min 
each), and four times (5 min each) in PBS. 
The blots were quantified by using the antoradiogram as a template to 
cut out the relevant bands, which were then counted in a gamma counter. 
To compensate for variations in the size (and, therefore, in the background) 
of the excised bands, a blank region of the blot was excised, counted, and 
weighed on an analytical balance to determine background counts per min- 
ute per microgram of nitrocellulose. This value was multiplied by the weight 
of  each excised band to determine the nonspecific background signal for that 
band, which was then subtracted from the total counts per minute to give 
the specific signal. This procedure gave linear responses in control experi- 
ments with all three antibody preparations using up to 50 t~g PNS protein 
per gel lane (see Fig.  1). In general, the specific signals were determined 
relative to an aliquot of the starting material; linearity was verified on each 
blot by including aliquots corresponding to 20 and  100%  of the initial 
sample. 
Generation and Purification of  Antisera 
Antisera against the native CI-MPR was prepared by multiple injections of 
a single rabbit with CI-MPR purified from bovine liver as described (32), 
except that the initial chromatography was performed on an Aft-Gel column 
conjugated with phosphopentamannose, not pbosphomannan.  The anti- 
CD-MPR was prepared using CD-MPR, also purified from bovine liver, 
that had been denatured with SDS and 2-mercaptoethanol. The anti-CD- 
MPR antibodies were purified by precipitation in 40% ammonium sulfate; 
the pellet was resuspended in 20 mM sodium phosphate, pH 7.0, 100 mM 
sodium chloride, 0.02 % sodium azide, and dialyzed against this buffer (57). 
The antibodies were affinity purified on a column of denatured CD-MPR 
coupled to cyanogen bromide-activated Sepharose (Pharmacia Fine Chemi- 
cals, Piscataway,  NJ) according to the suppliers instructions. Anti-CD- 
MPR antibodies were eluted with 0.2 M glycine, pH 2.5, and immediately 
neutralized with  1 M  Tris base. Preparations of anti-ASGP R  sera were 
generously provided by Dr. Alan Schwartz (Washington University) and Dr. 
Kurt Drickamer (Columbia University). All antisera and afftnity-purified 
antibodies were stored at  -20°C until use. 
The synthetic peptides used to generate antisera were conjugated to key- 
hole limpet hemocyanin by one of two methods. Method A: CI-MPR pep- 
tides Nos.  1 and 2 were synthesized with an extra cysteine residue at the 
amino terminus. The carrier protein was alkylated with iodoacetamide and 
desalted on Sephadex G-25.  10 mg was combined with 0.28  mg N-suc- 
cinimidyl-3(2-pyridyldithio)proprionate in 0.02  ml ethanol over 45  min, 
and desalted into 25 mM sodium phosphate, pH 7.5,  150 mM sodium chlo- 
ride (0.025  M  PBS). An equal weight amount of peptide was added and 
incubated for 20 h at 4°C. The mixture was dialyzed against 0.025  M PBS 
and stored at  -20°C. Method B: The CD-MPR peptide (5 mg) was com- 
bined with 10 mg of carrier protein in 2 ml 0.025  M PBS, and 0.5 ml of 
20 mM glutaraldehyde was added dropwise at 20°C. The mixture was in- 
cubated for 1 h, and then dialyzed and stored as above. 
The anti-peptide sera were raised by multiple injections of the peptide/ 
keyhole limpet hemocyanin conjugates in rabbits. The antigen (1 mg pep- 
tide/ml) was mixed in a 1.0:1.5 ratio with Freunds complete adjuvant (Gibco 
Laboratories, Grand Island, NY) to give a thick emulsion. This mixture 
(containing 200-300 ~g peptide) was injected at weeks 0, 3, and 5. Depend- 
ing on the response of each rabbit, subsequent injections (of 100-200 #g 
peptide) were made at weekly to monthly intervals. Blood was taken 7-10 d 
after each boost. Titers were estimated by immunoprecipitation of purified 
and t2SI-labeled C1-MPR or CD-MPR (see below). The anti-CI-MPR pep- 
tide No.  1 preparation (see Fig. 3) was derived from the serum of one of 
two rabbits which produced anti-eI-MPR antibodies; two additional rabbits 
did not respond. The anti-CI-MPR peptide No. 2 preparation came from 
the pooled sera of both rabbits that were immunized. The anti-CD-MPR 
peptide preparation came from pooled sera from two of the four rabbits 
which responded to that conjugate.  A  second CD-MPR peptide, corre- 
sponding to the carboxy-most  region of  the protein, failed to elicit antibodies 
capable of recognizing the mature protein in any of the four rabbits injected. 
All three anti-peptide sera were purified by ammonium sulfate precipitation 
and chromatography on MPR-scpharose columns as described above. 
Proteins were labeled with 12sI using the Iodogen procedure (14).  100 
#g of protein in 50 mM Tris, pH 7.4,  100 mM sodium chloride was added 
to a tube containing 20 #g of Iodogen, 5 #1 1 M Tris, pH 8.0, and 0.5 mCi 
Nal2SI (carrier free). The reaction was allowed to proceed for 10 min at 
room temperature, and the mixture was desalted on a 10 ml Sephadex G-25 
column equilibrated in I mg/ml BSA, 50 mM Tris, pH 7.4,  100 mM sodium 
chloride, and 0.02%  sodium azide. For the labeled antibodies, the protein 
peak was pooled and used directly. For the MPRs, 0.05%  Triton X-100 was 
included in the columns, and the protein peak was dialyzed extensively 
against 50 mM Imidazole, pH 6.5,  100 mM sodium chloride, 5 mM ~-glyc- 
erophosphate, 0.02%  sodium  azide  containing  10  mM  ED'I'A  (for the 
t2sI-C1-MPR) or 10 mM manganese chloride (for the 1251-CD-MPR).  The 
labeled receptors were then isolated by chromatography on phosphoman- 
nan-Sepharose in the appropriate buffer and eluted with 5 mM Man 6-P as 
has been described (32). 
Dynabead Preparation, Immunoisolation, 
and Recovery Calculations 
Uncoated Dynabeads M450 (Dynal, Inc.) were activated with p-toluenesul- 
phonylchloride and pyridine in acetone according to the directions supplied 
by the manufacturer. Approximately 300 mg of activated beads were then 
resuspended in water and an equal volume of  0.2 M sodium borate, pH 9.5, 
containing 5 nag of affinity-purified goat anti-rabbit IgG (Sigma Chemical 
Co.) was added. The reaction was allowed to proceed for 1 d at room tem- 
perature, after which the Dynabeads were isolated and washed in 100 mM 
sodium phosphate, pH 7.4,  100 mM sodium chloride. The unreacted sites 
were blocked by incubation in 1 M ethanolarnine, pH 9.5, for 2 h, and the 
beads were washed several times with 50 mM Tris, pH 7.4,  100 mM sodium 
chloride, 1 mg/ml BSA, and 0.02%  sodium azide, first with 0.1% Tween 
20 and then without. The Dynabead anti-rabbit antibody preparation was 
stored in this buffer at 4°C until use. 
Immediately before use, the Dynabeads were washed several times in 
wash buffer (25 mM Pipes, pH 7.4,  100 mM potassium chloride, 500 mM 
sucrose, 10 mM EDTA, 0.5% polyvinylpyrrolidone 40, and a  1:1,000 dilu- 
tion of protease inhibitor cocktail). The beads were saturated with an excess 
of afftnity-purified anti-peptide antibody (or nonimmune sera)  in wash 
buffer by end over end rotation for 5-6  h  at 4°C.  The final Dynabead/ 
anti-rabbit/anti-peptide antibody conjugates were  washed several times 
with wash buffer and then used for immunoisolation. The relative amounts 
of protein and Dynabeads used varied from experiment to experiment and 
are noted in the figure legends. In general, PNS samples were diluted to 1-2 
mg/ml in Dynabead wash buffer; fractions from the sucrose gradient were 
diluted with sucrose-free homogenization buffer to a final concentration of 
0.5 M sucrose, and diluted further to 0.3-0.5 mg/ml protein with 25 mM 
Pipes, pH 7.4,  100  mM potassium chloride, 500  mM sucrose,  10  mM 
EDTA, and a 1:1,000 dilution of protease inhibitor cocktail. The experiment 
illustrated by Table II was slightly different; the sucrose gradient fractions 
had been stored at  -20°C and thawed before immunoadsorption and the 
protein concentration was 1.0 mg/ml. Unless otherwise noted, immunoiso- 
lation was allowed to proceed with constant mixing overnight (12-14 h) at 
4°C. The Dynabeads were isolated with a magnet and the supernatant was 
removed and  saved for analysis.  The Dynabeads were washed twice by 
gentle resuspension in wash buffer and end over end rotation at 4"C for 
30-40 min. 
The washed beads were generally resuspended in half the volume of the 
supernatant and analyzed in immunoblots or for enzyme activities in paral- 
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amount of PNS protein was electrophoresed on 8 % polyacrylamide 
gels, transferred to nitrocellulose, and subjected to immunoblotting 
with specific antibodies followed by t2SI-labeled  second antibodies 
as described in Materials and Methods. The labeled bands were ex- 
cised from the blot and the specific 12s.I signal determined using a 
gamma counter. The best line was determined by least-squares anal- 
ysis. The insets contain autoradiograms of the regions of the blots 
which were quantified in this fashion. (A) CI-MPR. (B) CD-MPR. 
lel with the supernatants and aliquots of the initial fractions. The protein 
content was determined by elution of  the beads with Triton X-100 and analy- 
sis of these extracts by the method of Peterson (47). The fold-purification 
data presented in Table I were calculated by dividing the yield of  each activ- 
ity through the tv,  x~ step procedure by the yield of protein. The yield of each 
component is defined as the percent of total on the gradient found in pool 
IV times the percent adsorbed onto the Dynabeads. Some of  the experiments 
used to generate Table  I are shown in Fig. 8.  The yield data presented in 
Table II are for the immunoisolation step only. The input material was a su- 
crose gradient  pool  which contained the  indicated percentages of each 
respective component as listed under the activity column of Table  II. The 
percentages of protein, sialyltransferase, succinate-INT reductase, and acid 
phosphatase activities were determined on aliquots of the fractions used for 
immunoisolation; the remaining components were measured on a parallel 
gradient. 
Electron Microscopy 
Aliquots of PNS adsorbed to the Dynabeads were pelleted in a microfuge 
and overlayed with a solution of 8% paraformaldehyde, 0.2 M  Pipes, pH 
7.0, for 60 min. The fix solution was changed one time, and the samples 
were stored at 4°C or above. For Fig. 6 A, the fixed samples were rinsed 
with 1% osmium tetraoxide in 0.1 M sodium cacodylate, dehydrated in etha- 
nol, and embedded in Epon (25). For the immunogold labeling (Fig. 6, B 
and  C),  the pellets were infused with 2.1  M  sucrose and prepared for 
cryosectioning as has been described (24).  The sections were cut with a 
"cryo"  diamond knife (Diatome Co.,  Bienne,  Switzerland), thawed, and 
treated with 5%  newborn calf serum followed by 50 #g/ml protein A to 
block nonspecific antibody or protein A  binding sites on the beads. The 
specific antibodies used were (a) anti-CI-MPR antisera (as described in ref- 
erence 26),  and (b) afffinity-purified  rabbit antibodies to the bovine CD- 
MPR (a generous girl of Bernard Hoflack, EMBL). These were used at a 
dilution of 1:5. Single and double labeling was done according to the method 
of Geuze et al. (17). The sections were contrasted and dried in methyl cellu- 
lose (24);  in a  few cases they were negatively stained in  1% ammonium 
molybdate in 2%  methylcellulose (15 cp). 
Results 
Quantitation and Initial Fractionation  of the MPR- 
containing Membranes of  Bovine Liver 
Bovine liver is an easily obtainable tissue that is an excellent 
source for the purification of both the CI-MPR and the CD- 
MPR (32).  Since these two proteins differ significantly in 
both molecular weight and immunological properties (32), 
they can be individually quantified by immunoblotting. Fig. 
1 shows the results of the blotting protocols we have devel- 
oped as applied to a total PNS fraction from bovine liver. In 
each case, a single major band is identified with the apparent 
molecular weight of the corresponding MPR purified from 
bovine liver (not shown) and the signals obtained are linear 
over a suitable range of PNS protein (0-50 #g). These proce- 
dures  can quantitatively distinguish  between the CI-MPR 
and the CD-MPR in mixed preparations of the two, a  re- 
quirement we were not able to meet with any of a variety of 
ligand binding procedures examined (e.g., see references 15, 
58).  Quantitative immunoblotting, therefore, has been our 
method of choice for documenting the purification of CI- 
MPR-  and  CD-MPR-containing  membranes  from bovine 
liver. 
Fractionation of bovine liver PNS by sedimentation on a 
15-45%  linear sucrose gradient gave the results shown in 
Fig. 2. This procedure clearly separates the bulk of the CI- 
MPR and the CD-MPR (Fig. 2 A) from dense lysosomes and 
cytosolic protein (Fig. 2 B). It should be noted that a signifi- 
cant fraction of the B-hexosaminidase remained at the top of 
the gradient, indicative of leakage from or partial rupture of 
lysosomes.  2 Both MPRs comigrate to varying extents with 
markers for the Golgi complex (galactosyltransferase), endo- 
somes (the ASGP R), and the plasma membrane (5' nucleoti- 
dase) in this gradient system (Fig. 2 C). The two MPRs have 
distinct profiles; the CI-MPR is broadly distributed in frac- 
tions 4-8,  while the  CD-MPR  is  particularly enriched in 
fractions 7 and 8. When fractions 6-9 were pooled, the CI- 
MPR and the CD-MPR were purified approximately four- 
and sixfold, respectively, over the initial PNS fraction. Since 
this pool consisted of a variety of liver membranes with very 
similar physical properties, we reasoned that further puri- 
fication would require a  specific technique capable of sep- 
arating the membrane vesicles and organelles on the basis of 
their MPR content, rather than size or density. To accom- 
plish this,  we took advantage of the  fact that each of the 
MPRs contains a portion which is exposed to the cytoplasmic 
2. The fractionation of rat liver PNS has been examined in similar experi- 
ments: <10% of the total B-hexosaminidase activity remained at the top of 
the gradient. It appears, therefore, that a significant fraction of the bovine 
liver lysosomes are less stable than those from the rat. 
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Figure 2. Fractionation of bovine liver PNS by sedimentation  on su- 
crose gradients. An aliquot of PNS (60 mg protein) prepared from 
bovine liver was sedimented at 110,000 g for 14 h on a 15-45% lin- 
ear sucrose gradient. The fractions were collected from the bottom 
and analyzed for the indicated constituent as described in Materials 
and Methods. The components examined and their recoveries on 
the gradient (expressed as the percent of each applied) are as fol- 
lows: (A) CI-MPR  (=),  71% recovered; CD-MPR  (t2), 101% re- 
covered; sucrose (A) concentrations. (B) Total protein (¢), 100% 
recovered; /~-hexosaminadase (<>), 81% recovered. (C) ASGP R 
(~) 60% recovered; galactosyltransferase (&), 90% recovered; 5' 
nucleotidase (zx), 55% recovered. 
surface. This allowed the development of a specific immuno- 
isolation procedure. 
Generation of  Antisera Specific for the Cytoplasmic 
Domains of the MPRs and Development of the 
lmmunoisolation Procedure 
The complete amino acid sequences of the bovine CI-MPR 
and CD-MPR have been deduced from their eDNA clones 
(9,  39).  This information, together with a  variety of bio- 
chemical experiments, indicates that both MPRs are oriented 
with the bulk of their mass on the lumenal side of intracellu- 
lar membranes (and the cell exterior of the plasma mem- 
brane), where these regions participate in ligand binding (9, 
53,  55).  The orientation of intracellular membranes  after 
homogenization is such that the much smaller cytoplasmic 
domains of the MPRs would be expected to be exposed in 
a vesicle or organelle preparation. To obtain antibody prepa- 
rations with the highest possible titer towards these struc- 
tures, a series of synthetic peptides corresponding to several 
regions of the cytoplasmic domains of the CI-MPR and CD- 
MPR were used as antigens (as described in Materials and 
Methods).  Three of the  peptides  resulted  in antisera  that 
proved to be capable of specifically recognizing the corre- 
sponding mature protein. Fig. 3 A illustrates the approximate 
location of these peptides in the CI-MPR and the CD-MPR. 
Immunoprecipitation experiments  using  purified  and  t2sI- 
labeled MPRs established that each antibody recognizes only 
the "correct" MPR, and does not cross react with the other 
(Fig. 3 B). The two different anti-CI-MPR peptide antibod- 
ies gave very similar results in all of our experiments; in 
general we present data from only one of these for simplicity. 
The immunoisolation matrix chosen for these experiments 
is a commercially available polystyrene bead embedded with 
a ferric oxide material (Dynabeads) which can be rapidly re- 
moved from a suspension of membranes with a standard bar 
magnet.  Goat anti-rabbit antibodies were chemically con- 
jugated to the Dynabeads and saturated with affinity-purified 
anti-MPR peptide antibodies as described in Materials and 
Methods. Initial experiments to optimize the conditions used 
for immunoisolation were performed using the PNS fraction 
prepared from bovine liver; some of these are shown in Fig. 
4. In general, the extent of immunoadsorption was evaluated 
by quantitative Western blotting of the Dynabead-bound and 
supernatant fractions. Near maximal immunoadsorption of 
the MPR-containing membranes was achieved by overnight 
incubation with •5  mg of  antibody-saturated Dynabeads per 
mg of PNS protein (Fig. 4, A and B).  Under these condi- 
tions,  ,'~40%  of the total CI-MPR  could be bound to the 
anti-CI-MPR peptide beads,  while nearly 20%  of the CD- 
MPR bound to the anti-CI-MPR peptide beads. Nonspecific 
binding of membranes to the beads was very low (only a few 
percent) as determined by using Dynabeads which had been 
prepared with nonimmune sera (Fig. 4). Specific immunoad- 
sorption could be blocked in each case by including an excess 
of the relevant peptide in the incubation, while a nonrelevant 
peptide had no significant effect (Fig. 4  C). 
A Population of  Liver Membranes Contains Both the 
CI-MPR and the CD-MPR 
Analysis of the various immunoadsorbed preparations re- 
vealed that the CD-MPR was enriched in membranes iso- 
lated using the anti-CI-MPR peptide antibodies, and the CI- 
MPR is enriched in membranes isolated on the basis of their 
CD-MPR content (Fig. 5). This was not observed when the 
membranes  were  solubilized  with  1%  Triton  X-100  (not 
shown). When the total PNS fraction was immunoadsorbed, 
there was roughly twice the percent of total CI-MPR com- 
pared to the percent of total CD-MPR on the Dynabeads. 
This ratio is approximately the same in membranes isolated 
with antibodies specific for either receptor (Fig.  5, inset). 
Furthermore,  sequential  or concurrent immunoadsorption 
with both the anti-CI-MPR  beads and the anti-CD-MPR 
beads did not result in a yield significantly greater than that 
obtained with a comparable level of one or the other alone 
Messner et al. Mannose 6-Phosphate Receptor-enriched Membranes  2153 Figure 3. Generation of anti-peptide sera that recognize the mature CI-MPR and CD-MPR. (A) The two MPRs are diagrammed schemati- 
cally with the homologous repeating units  (represented by rectangles),  the putative transmembrane regions (as jagged lines),  and the 
carboxy-terminal cytoplasmic tails containing the peptides used in this study.  The amino acid sequences of the peptides are given. The 
peptides have been designated as CI-MPR peptide Nos.  1 and 2, which correspond to residues 2408-2421  and 2482-2499,  respectively, 
of the 2,499-amino acid sequence deduced from the cDNA clones obtained for the bovine CI-MPR (39). The CD-MPR peptide corresponds 
to residues  198-212  of the 257-amino acid CD-MPR sequence,  also as deduced  from cDNA clones (9).  (B) Immunoprecipitation of 
mI-CI-MPR and ~25I-CD-MPR by the anti-peptide sera. Equivalent aliquots of 125I-CI-MPR or ~2~I-CD-MPR were immunoprecipitated 
with  saturating  levels of each of the peptide sera,  followed by protein A-Sepharose as described  in Materials and Methods.  The im- 
munoprecipitates were boiled in SDS sample buffer and subjected to SDS-PAGE on a gradient gel of  4-12% acrylamide, followed by autora- 
diography at -70°C for 19 h (lanes 1-3) or 6 h (lanes 4-6). The antisera and percent of total J2SI-MPR immunoprecipitated in each case 
are as follows:  lane 1, anti-CI-MPR peptide No.  1, 20% of total t25I-CI-MPR;  lane 2, anti-CI-MPR peptide No. 2, 9% of total ~25I-CI- 
MPR; lane 3, anti-CD-MPR peptide, <1%  of total ~2~I-CI-MPR; lane 4, anti-CI-MPR peptide No.  1, <1%  of total  t25I-CD-MPR; lane 
5,  anti-CI-MPR peptide No. 2, <1%  of total ~25I-CD-MPR;  lane 6, anti-CD-MPR peptide,  39%  of total  t2sI-CD-MPR. The maximal 
level of ~25I-CI-MPR capable of being immunoprecipitated by the anti-CI-MPR peptide sera (particularly anti-CI-MPR peptide No. 2) 
is somewhat low, and is variable from preparation to preparation of CI-MPR. This value is very reproducible for a given batch of t25I-CI- 
MPR. In addition,  we have observed that the cytoplasmic domain of the Triton-solubilized CI-MPR is highly susceptible to proteolysis 
by added trypsin. It is likely,  therefore, that a certain amount of degradation of the cytoplasmic domains occur during homogenization 
and purification, despite the extensive use of protease inhibitors, and that this prevents quantitative immunoprecipitation of the t25I-MPRs. 
(data not shown).  These findings indicate that the bulk of the 
membranes isolated by the anti-CI-MPR beads are also iso- 
lated by the anti-CD-MPR beads. Since the efficiency of im- 
munoisolation has been shown to be highly dependent on the 
surface density of antigen (28), we conclude that the purified 
preparations  represent  those  membranes  with  the  highest 
density of antibody-accessible CI-MPR and CD-MPR in the 
liver. Clearly both receptors are enriched in the same mem- 
branes. 
Analysis of the immunoadsorbed PNS  fractions by elec- 
tron microscopy (Fig.  6 A) revealed that the purified mem- 
branes  consisted  of a  heterogeneous  population  of tubules 
and  vesicles  that  were  not  present  on  the  control  (nonim- 
mune)  beads  (not  shown).  The  membranes  were  indistin- 
guishable regardless of which MPR antibody was used in the 
immunoisolation.  Readily identifiable organelles, such as mi- 
tochondria,  plasma membrane sheets,  or Golgi stacks were 
absent or infrequently detected. Immunogold labeling of thin 
frozen sections prepared from the purified membranes with 
specific anti-receptor antisera and protein A-gold confirmed 
the  presence  of membranous  structures  which  contain  the 
CI-MPR and the CD-MPR (Fig. 6, B and C). The specificity 
of the immunolabeling was verified by the much lower levels 
of gold particles when the sections were (a) treated with pro- 
tein A-gold in the absence of the specific antibodies,  or (b) 
treated  with  either  affinity-purified  antibodies  against  the 
vesicular stomatitis virus "G" protein or an antiserum against 
the spike-protein complex of Semliki forest virus,  followed 
by  protein  A-gold.  When  these  controls  were  quantified 
(22),  there  was  an  average of 0.92  +  0.45  gold  particles/ 
/~m  z membrane  (mean  +  SEM,  n  =  23  micrographs)  for 
membrane preparations isolated on the basis of either the CI- 
MPR or the CD-MPR content.  This compares with the sig- 
nals obtained using the anti-CI-MPR antibody for immuno- 
labeling of 8.43  +  1.47 (CI-MPR-enriched membranes, n  = 
34) and 8.63  +  1.44 (CD-MPR-enriched  membranes, n  = 
41). The corresponding signals using the anti-CD-MPR anti- 
body were 3.39 +  0.95 (CI-MPR-enriched membranes, n  = 
16) and 2.84  4- 0.60 (CD-MPR-enriched  membranes,  n  = 
20).  These data  supply  additional  evidence to  support  our 
conclusion that the CI-MPR shares the same membrane as 
the CD-MPR. 
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Figure 4. Immunoisolation  of MPR-enriched membranes using Dy- 
nabeads. (A) Fraction of the total MPR absorbed by saturating Dy- 
nabeads. Dynabead conjugates were prepared with affinity-purified 
anti-CI-MPR peptide  No. 2.  (A),  anti-CD-MPR peptide  (=), or 
nonimmune  sera (a, []), and incubated with bovine liver PNS that 
had been diluted to 1 mg protein/ml. The indicated amount of Dy- 
nabeads were incubated overnight with 1 mg PNS protein, isolated 
with a magnet, washed, and prepared  for SDS-PAGE as described 
in Materials and Methods.  After electrophoresis,  the samples were 
transferred  to nitrocellulose and subjected to immunoblotting  with 
anti-CI-MPR (triangles) or anti-CD-MPR (squares), followed by 
t2SI-labeled second antibody. The relative amount of MPR in each 
sample  was quantified  in a gamma counter and is expressed  as a 
percentage of the starting material. (B) Time course of immunoiso- 
lation.  Two  milligrams of each  Dynabead preparation were  in- 
cubated with 1 mg PNS protein for the indicated time and analyzed 
as described above. The symbols are identical to those used in A. 
(C) Block of immunoisolation  by the peptides used to generate the 
anti-MPR sera. A 2-rag aliquot of the indicated Dynabead prepara- 
tion was preincubated for 30 min alone (-), or with  100/zg of ei- 
ther the peptide used to generate the antisera ([]) or a nonrelevant 
peptide  (NH2-CFYLFEMDSSLAC-COOH)  (o)  in  Dynabead 
wash containing  0.25 M sucrose. One milligram  of PNS protein was 
added,  the mixtures were incubated overnight,  and then analyzed 
as described above to determine the percentage of total CI-MPR im- 
"O 
0 
"IJ 
rr 
4O 
3O 
10 
O4 
II 
Q. 
21 
¢',1 
0  "E 
=  g 
e- 
Figure 5. Codistribution of the CI-MPR and the CD-MPR in liver 
membranes isolated from the PNS fraction. The indicated antibody 
preparations  were  conjugated  to  Dynabeads and used  to  isolate 
membranes from bovine liver PNS as described in Materials  and 
Methods.  The samples were analyzed for the CI-MPR ([]) and the 
CD-MPR ([]) by quantitative immunobtotting and the results are 
expressed  as the percentage  of each  MPR adsorbed  on the  Dy- 
nabeads. The data shown are the mean +  the standard error of the 
mean of six experiments,  three  of which used  fresh bovine liver 
PNS  in Dynabead wash containing 0.5  M  sucrose,  and three  of 
which were done on PNS aliquots that had been frozen, using 0.25 
M sucrose in the Dynabead wash. There was no significant differ- 
ence between these two groups. The ratios of CI-MPR to CD-MPR 
in the membranes isolated on the immune beads (CI/CD) were de- 
termined separately in each of the six experiments.  The mean val- 
ues are shown in the inset, expressed relative to the initial PNS frac- 
tion (which was taken as one). 
The MPR-enriched Membranes Have 
Biochemical Characteristics Which Are Distinct from 
Other Intracellular Organelles 
To optimize the purification of MPR-containing  membranes, 
various fractions from a  sucrose gradient were podled and 
used as input fractions for immunoisolation. The samples 
were then analyzed and compared for maximal adsorption of 
the CI-MPR and the CD-MPR, and minimal adsorption of 
protein. Pool IV, corresponding to fractions 7-8 of the gra- 
dient profiles illustrated in Fig. 2 and representing a density 
range of 1.104-1.123 g/ml, showed the highest enrichment in 
MPR-containing membranes (Fig. 7). 
When the immunoadsorbed  pool IV membranes were ana- 
lyzed for the presence of various enzymes of known subcel- 
lular distribution, the results shown in Fig. 8 were obtained. 
The data are presented as the yield (see the legend to Fig. 
8)  of each respective component through the sucrose gra- 
dient and immunoisolation  steps in each of two experiments. 
munoadsorbed on the anti-CI-MPR peptide beads and the percent- 
age of total CD-MPR immunoadsorbed to the anti-CD-MPR pep- 
tide beads.  The nonimmune beads were analyzed  for both MPRs 
as indicated. 
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Figure 7. Immunoisolation of membranes enriched in the CI-MPR 
and CD-MPR after partial  purification on a sucrose density gra- 
dient. An aliquot of  bovine liver PNS was fractionated  on a 15--45  % 
linear sucrose gradient as described in Materials  and Methods and  o 
the legend to Fig. 2. Fractions 1-10 (of 14 total) contained the bulk  "~ 
of the membrane protein and were grouped into five pools for im- 
munoadsorption as follows: Pool I, fractions 1-2; Pool H, fractions  "~ 
3--4; Pool III, fractions 5-6; Pool IV, fractions 7-8; Pool V, fractions 
9-10. An aliquot of each pool (containing ,~0.6 mg membrane pro- 
tein) was adsorbed with 6 mg of one of the Dynabead preparations: 
anti-CI-MPR peptide  No. 2  (~),  anti-CD-MPR peptide (ms), or 
nonimmune sera (g). After immunoisolation,  the membranes  were 
either analyzed for CI-MPR content (top row) or CD-MPR content 
(middle row) by quantitative  immunoblotting,  or extracted from the 
Dynabeads with Triton  X-100 for protein determination  (bottom 
row). The percent immunoadsorption of each component is given 
relative  to the total  recovered from the entire sucrose gradient. 
Both  anti-MPR  bead  preparations  were  substantially  en- 
riched (relative to the adsorbed protein) in the CI-MPR, the 
CD-MPR, and the ASGP R. The latter receptor is known to 
be distributed primarily between the plasma membrane, en- 
dosomes, and the Golgi complex (66).  Smaller amounts of 
galactosyltransferase, 5' nucleotidase, and 13-hexosaminidase 
were seen. These are generally taken as markers of the Golgi 
complex, the plasma membrane, and lysosomes, respective- 
ly (42, 50). Table I shows the purification of each component 
(relative to total protein)  following the two step procedure. 
When the Dynabeads were prepared with the anti-CI-MPR 
antibodies, the purified membranes were 50-fold enriched in 
the CI-MPR, 42-fold enriched in the CD-MPR, and 31-fold 
enriched in the ASGP R, with a much lower relative content 
of the other components.  Similarly, the anti-CD-MPR Dy- 
nabeads gave preparations  which were 50-fold enriched in 
the CD-MPR, 30-fold enriched in the CI-MPR, and 38-fold 
enriched in the ASGP R. These data indicate that the MPR- 
enriched membranes are associated with the endocytic path- 
way, but are not significantly derived from the Golgi or the 
plasma membrane. 
To examine  whether  the  MPR-enriched  membranes  are 
distinct from the TGN as well as the Golgi stacks, a slightly 
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Figure 8. Characterization of  marker enzymes in the highly purified 
CI-MPR- and CD-MPR-enriched membranes.  The CI-MPR- and 
CD-MPR-enriched membranes were isolated from the region of a 
sucrose gradient corresponding to Pool IV (Fig. 7), adsorbed to Dy- 
nabeads,  and analyzed for the indicated  protein or enzyme activity 
as described in Materials and Methods. The data are taken from two 
experiments.  In experiment  1 (represented  in all panels by m), a 
Dynabead to membrane protein ratio  of 10 mg/mg was used.  In 
experiment  2  (~),  the  ratio  was  6  mg/mg.  5' nucleotidase  and 
~-hexosaminadase  activities were not analyzed in experiment 2. (A) 
CI-MPR-enriched membranes, isolated with anti-CI-MPR peptide 
No.  1 antibodies. (B) CD-MPR-enriched membranes,  isolated with 
anti-CD-MPR peptide  antibodies.  (C) Nonimmune background, 
determined using nonimmune sera coupled to the Dynabeads. 
Figure 6. Immunogold labeling  and electron microscopy of immunoisolated  membranes. Immunoadsorbed PNS fractions were fixed in 
8 % paraformaldehyde and embedded in Epon (A) or frozen, sectioned,  and labeled  with antibodies  and protein A-gold (B and C) as de- 
scribed in Materials  and Methods. The Dynabeads are identified  with a white B. (A) Membranes isolated with anti-CI-MPR peptide No. 
1 beads.  (B) Cryosections of the membranes adsorbed to the anti-CI-MPR peptide No.  1 beads,  double labeled  for the CI-MPR (5-rim 
gold, arrows) and the CD-MPR (9-nm gold, arrowhead). (C) Membranes adsorbed to the anti-CD-MPR peptide  beads,  double labeled 
as in B.  Bars,  200 nm. 
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Sucrose Gradient Centrifugation (Pool IV) and 
Immunoisolation* 
Membranes  isolated with 
Activity  Anti-CI-MPR  peptides  Anti-CD-MPR  peptide 
CI-MPR  50  (n  =  4,  39-56)  30  (n  =  3,  22-39) 
CD-MPR  42  (n  =  3,  30-52)  50 (n  =  2,  26-75) 
Galactosyltransferase  7  (n  =  3,  4-11)  14  (n  =  2,  5-23) 
ASGP R  31  (n  =  3,  23-39)  38  (n  =  2,  21-55) 
5' Nucleotidase  6 (n  =  2, 6-7)  5 (n  =  1) 
B-Hexosaminidase  0.7  (n  =  2,  0.4-1.0)  I  (n  =  I) 
* The fold-purification of each component was calculated as described in Ma- 
terials and Methods.  Mean values are presented,  with the number of experi- 
ments (n) and the range of values obtained given in parentheses.  The starting 
PNS has a value of one for all components. 
broader pool of membranes which contained the bulk of the 
sialyltransferase activity (a marker for the TGN) was used 
as the input fraction (Table II). Fractions 6-10 (out of 15 to- 
tal), representing a density range of 1.087-1.134 g/ml, were 
pooled and immunoadsorbed with either anti-CI-MPR or 
anti-CD-MPR Dynabeads. Approximately 45 and 30% of 
the CI-MPR in the pool was recovered on the anti-CI-MPR 
or anti-CD-MPR Dynabeads, respectively, along with only 
2% of the protein. These same fractions contained •35%  of 
the CD-MPR, but only 10-13% of the galactosyltransferase 
activity and 8-9% of the sialyltransferase activity. The rela- 
tive amount of galactosyltransferase that was  co-adsorbed 
from this pool was slightly higher than that seen from pool 
IV, but sialyltransferase was no more enriched than galac- 
tosyltransferase, supporting our conclusion that the bulk of 
the MPR-enriched membranes are not derived from the TGN 
or the Golgi stacks. Only 8 % of the succinate-INT reductase 
activity sedimented in fractions 6-10 of the sucrose gradient, 
and <10%  of this was immunoadsorbed by the anti-MPR 
Dynabeads, indicating that mitochondria are not being en- 
riched for in this procedure (Table II). Both the galactosyl- 
transferase and the MPRs were somewhat more enriched af- 
ter immunoisolation from this broader pool of light/medium 
density membranes,  with a  greater overall yield (compare 
Table I and Fig.  8 with Table II). 
This pool was also used to evaluate the distribution of acid 
phosphatase  (a lysosomal enzyme) among the immunoad- 
sorbed fractions. There are many different forms of this ac- 
tivity which have been distinguished in a variety of ways, one 
of which is based on whether they are sensitive or resistant 
to inhibition by (+)-tartrate (36). The tartrate-resistant form 
of acid phosphatase found in bovine liver sedimented on a 
sucrose gradient  with  a  profile similar to that  shown  for 
B-hexosaminidase in Fig. 2 (not shown). The profile of the 
tartrate-sensitive form differed in two ways. First, much less 
was seen at the top of the gradient (not shown). This would 
be expected if some of this enzyme was  membrane asso- 
ciated, as has been reported for a lysosomal tartrate-sensi- 
tive acid phosphatase from human placenta (63). Second, a 
greater percentage of the tartrate-sensitive form was observed 
to co-sediment with the membranes of light to medium den- 
sity (fractions 6-10) which contained the bulk of the Golgi 
enzymes and the MPRs (Table II). When these membranes 
(fractions 6-10) were incubated with the anti-MPR Dyna- 
beads, only 3 % of the tartrate-resistant acid phosphatase ac- 
tivity was coadsorbed, while 23%  of the tartrate-sensitive 
activity was isolated (Table II). Apparently the tartrate-resis- 
tant form of acid phosphatase, like B-hexosaminidase (Fig. 
8), has a subcellular distribution which does not significantly 
overlap with the MPRs. In contrast, a significant portion of 
the tartrate-sensitive acid phosphatase found in liver appears 
to be distributed in MPR-enriched membranes. 
Polypeptide Composition of the Isolated CI-MPR- and 
CD-MPR-enriched Membranes 
To determine the polypeptide composition of the purified 
MPR-enriched membranes, the Dynabead fractions were ex- 
tracted with 1% Triton X-100 after immunoadsorption. Un- 
der these conditions, the extracts contain the proteins not 
directly coupled (via the antibodies) to the beads. Analysis 
of the extracts by SDS-PAGE and silver staining  (Fig.  9) 
showed that there was significantly more membrane protein 
on the immune beads compared to the nonimmune beads, as 
expected from the protein analysis (Fig.  8).  The CI-MPR 
and the CD-MPR are not major bands in any of the lanes, 
and in fact may not even be detectable, since even after a 50- 
fold purification they would only represent "~1% of the pro- 
tein in the extract. The majority of  bands in the lanes contain- 
ing the purified membranes are also seen in roughly the same 
relative concentrations in the initial PNS or Pool IV frac- 
tions. There are, however, several examples of high molecu- 
lar weight proteins which are significantly enriched in the 
isolated membranes.  Most noticeably, the membranes iso- 
lated with the anti-CI-MPR beads are particularly enriched 
in a 400-kD protein, while the membranes isolated with the 
anti-CD-MPR  beads  are  strikingly enriched in a  170-kD 
protein, and to a lesser extent a 185-kD protein (arrows, Fig. 
9). Each of these proteins is less enriched in the other puri- 
fied membrane preparation, and is barely detectable or unde- 
tectable in the pool IV or PNS fractions. Since the CI-MPR 
has been localized to clathrin-coated vesicles (8, 53), which 
contain as the major polypeptide the 180-kD heavy chain of 
clathrin,  it seemed likely the  170- or  185-kD bands might 
correspond to this protein. There was, however, no enrich- 
ment for clathrin heavy chain in any of these fractions, as de- 
termined by immunoblotting (data not shown). The identity 
of these three enriched proteins is,  at present, unknown. 
Table II.  Yield of  Marker Activities after lmmunoisolation 
from the Sucrose Gradient Pool (fractions 6--10)* 
Activity (percent total 
in fractions 6-10) 
Membranes  isolated with 
Anti-CI-MPR  No.  2  Anti-CD-MPR 
%  % 
Protein  (15%)  2.3  2.1 
CI-MPR (50%)  45  30 
CD-MPR  (65%)  42  35 
Galactosyltrans  ferase (59%)  14  10 
Sialyltransferase (61%)  9  8 
Succinate-INT reductase (8%)  6  <1 
Acid Phosphatase 
Tartrate resistant (15%)  3  3 
Tartrate sensitive (28%)  23  23 
* Yield refers to the recovery of each component from immunoisolation alone. 
Details are given  in Materials and Methods. 
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enriched membranes by SDS-PAGE  and silver staining. Total PNS 
membranes were sedimented on a sucrose gradient (SG) and the 
region corresponding to pool IV (see the legend to Fig. 7) was 
immunoadsorbed with Dynabeads containing either anti-CI-MPR 
peptide No. 1, anti-CI-MPR peptide No. 2, anti-CD-MPR peptide, 
or nonimmune antibodies as described in Materials and Methods. 
The Dynabead fractions were extracted with Triton X-100 and ali- 
quots (5 % of the total) were prepared for SDS-PAGE,  together with 
aliquots of the PNS (0.1% of the total) and pool IV (0.2% of the 
total).  After electrophoresis,  the 4-12%  gradient gel was  silver 
stained; the positions of molecular weight standards are as shown. 
The arrows indicate the positions of bands which appeared to be 
particularly enriched in the immunoisolated preparations. 
Discussion 
The primary goals of this work have been to (a) develop a 
method to specifically purify those membranes from bovine 
liver which contain the highest densities of  CI-MPR and CD- 
MPR,  (b)  evaluate whether each MPR  is  enriched in the 
same, or different populations of membranes, (c) determine 
the most likely cellular organelles from which these mem- 
branes  are  derived,  and  (d)  identify other molecules en- 
riched in these organelles to begin to address the fundamen- 
tal question of how these particular membranes are involved 
in  the  targeting  and  cycling  of the  MPRs.  We  have  ap- 
proached these points by taking advantage of the specificity, 
simplicity, and nondisruptive nature of immunoisolation on 
magnetic beads. As first described by Howell et al. (10, 35), 
the use of Dynabeads permits a more gentle isolation proce- 
dure than other solid supports such as polyacrylamide beads 
or formalin fixed Staphylococcus aureus cells, since the need 
for potentially disruptive pelleting and resuspension steps is 
eliminated.  The MPR-containing membranes isolated with 
this technique are a complex mixture of heterogenous vesi- 
cles and tubules (Fig. 6) which appear to be very similar to 
some of the MPR-containing organelles seen in whole cells 
(21, 26). This observation supports our belief  that we are iso- 
lating intact structures with minimal vesiculation and break- 
age. The immunoisolation step is specific, as judged by our 
ability to block membrane binding to the Dynabeads with the 
respective peptides used to generate the antibodies as well 
as by the low yield of MPRs on the nonimmune Dynabeads. 
When combined with an initial fractionation on sucrose den- 
sity gradients, the immunoisolation protocol results in mem- 
brane preparations which are enriched ~o50-fold in the CI- 
MPR and the CD-MPR (Table I). 
The bulk of the immunoadsorbed membranes are not de- 
rived from the Golgi, since there was a much greater enrich- 
ment of the CI-MPR and the CD-MPR compared to galacto- 
syltransferase and sialyltransferase (Tables I and II), markers 
of the trans-Golgi  cisternae and TGN, respectively (2, 50, 
51). There was also an insignificant amount of plasma mem- 
brane in  these fractions,  as judged by the low yield of 5' 
nucleotidase (Fig.  8), and no enrichment for mitochondria 
(2-[p-iodophenyl]-3-[p-nitrophenyl]-5-phenyltetrazolium 
reductase) or lysosomes (/$-hexosaminidase and tartrate-re- 
sistant acid phosphatase). The tartrate-sensitive form of acid 
phosphatase which sedimented on the sucrose gradients with 
the membranes of light and medium density was significantly 
enriched in the purified preparations (Table II). The subcel- 
lular distribution of this activity is not known at a quantita- 
tive level; it is enriched in lysosomes but is present in other 
compartments as well (63). It was one of the criteria used 
by Novikoff and co-workers to identify GERL, a compart- 
ment which was originally proposed to include the regions 
of the Golgi and endoplasmic reticulum responsible for lyso- 
some formation (29). Most of  the membranes thought to com- 
prise GERL have more recently been classified as part of the 
TGN (23). It is interesting, therefore, that a higher percent 
of the tartrate-sensitive acid phosphatase activity is recov- 
ered from the sucrose gradient pool after immunoadsorption 
than the Golgi marker sialyltransferase (23 vs. 8 %, Table II). 
Apparently the tartrate-sensitive acid phosphatase is not only 
present in the TGN, but also in the endocytic structures that 
contain the MPRs,  while sialyltransferase is probably con- 
fined to the TGN or trans-Golgi  cisternae. 
Most of the CI-MPR found in liver is distributed among 
endosomes, the Golgi complex, and the plasma membrane 
(7,  19).  The lack of coenrichment of markers for the latter 
two organelles suggest,  therefore, that the membranes we 
have isolated are endosomes. This is supported more directly 
by several observations. First, there is a 30--40-fold enrich- 
ment for the ASGP R in both the CI-MPR and the CD-MPR 
membrane preparations (Table I). The ASGP R, a receptor 
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teins, is particularly enriched on the plasma membrane and 
in endosomes (18, 66). Second, the isolated membranes are 
comprised of a heterogeneous population of vesicles and tu- 
bules, which is consistent with the morphological character- 
istics of endosomes in intact cells or after purification (11, 
34, 41, 43, 64).  Finally, the total purification (40-60-fold, 
Table  I)  and  yields  (22-23%,  Table  II)  that  have  been 
achieved for the CI-MPR and the CD-MPR-enriched mem- 
branes  using our procedures  compare  favorably with the 
values reported for the purification of  endosomes by other in- 
vestigators. Dickson et al.  (11) used density gradient cen- 
trifugation and size exclusion chromatography to purify vesi- 
cles  containing newly endocytosed  ~25I-EGF 23-fold over 
the PNS fraction prepared from KB carcinoma cells, with a 
yield of 13 %. Hornick et al. (34) also used a density gradient 
approach to purify vesicles containing endocytosed ~5I-LDL 
from rat liver PNS 73-fold with a yield of 12%.  Marsh et 
al. (41) obtained a 42-fold purification and a 12 % yield of en- 
dosomes from the PNS fraction of CHO cells using Percoll 
gradient centrifugation followed by free flow electrophore- 
sis.  The procedures we describe are less time consuming 
than the approaches using multiple density gradients, and 
they do not require the initial trypsin treatment of the mem- 
branes necessary for effective separation by free flow electro- 
phoresis (41), which would probably destroy the cytoplasmic 
domains of the MPRs. Thus, while we have not established 
through functional experiments that the MPR-enriched mem- 
branes represent endosomes, the composition, morphology, 
and purification factors of these structures are nearly identi- 
cal to the vesicles purified by other investigators based on the 
content of newly endocytosed material. 
Immunoisolation  of subcellular organelles has been shown 
to be highly dependent on the surface density of antigen (28), 
and so it seems likely that we are isolating only those mem- 
branes with the highest density of MPRs. The CI-MPR and 
CD-MPR which can not be isolated may be distributed over 
a larger surface area of liver membranes at a density below 
that required for efficient adsorption to the Dynabeads. Both 
the Golgi stacks and the TGN may fall into this category, as 
suggested by the lack of coenrichment of galactosyl transfer- 
ase and sialyltransferase (Fig. 8, Tables I and II). Other fac- 
tors  which may contribute to a  immunoisolation yield of 
<100%  include:  (a)  the  presence  of large,  multilamellar 
structures  in  which  the  MPRs  are  not accessible  to  the 
Dynabead-antibody complex, (b)  partial proteolysis of the 
MPR cytoplasmic domains, such that the membranes can not 
be recognized by the anti-peptide antibodies,  3 (c) distribu- 
tion of a  fraction of the MPRs on the plasma membrane, 
which re-seals upon homogenization such that the cytoplas- 
mic domain is inside the vesicles (1, 49),  (d) the presence 
of low affinity antibodies in our preparations which can not 
maintain their attachment during the washing procedures, 
or limited membrane vesiculation and breakage during the 
washing procedures, and (e) the presence of cellular proteins 
which bind to the cytoplasmic domains of the MPRs and 
effectively compete with the antibodies. 
3. Immunoblotting experiments with the anti-CI-MPR peptide No. 2 sera 
show that at least some of the CI-MPR which is not immunoadsorbed does 
possess an intact cytoplasmic domain. The technique is not sensitive enough 
to be quantitative, however, and so proteolysis remains a potential contribut- 
ing factor here. 
Two MPR-enriched endosomal compartments have been 
identified by immunoelectron microscopy which differ in 
their location within the cell, the relative time required for 
endocytosed ligands to accumulate within each, and the rela- 
tive effect of low temperature on the flux of material through 
each. Geuze et al. (20) have identified a peripheral compart- 
ment in both rat liver and Hep G2 cells, termed CURL (for 
Compartment of Uncoupling of Receptor and Ligand), which 
is a relatively early endocytic structure that is enriched in 
both the CI-MPR and the ASGP R. The ASGP R and its li- 
gands are thought to dissociate in these early endosomes (18, 
21).  The vesicles and tubules which comprise CURL are 
similar in appearance to the immunoisolated membranes we 
have obtained. This, together with the high content of ASGP 
R in the MPR-enriched membranes, suggests that early en- 
dosomes probably represent at least a portion of these struc- 
tures.  More  recently, a  late endosomal compartment has 
been identified in the Golgi region of NRK cells which is 
characterized by a very high density of CI-MPR (26).  This 
compartment was shown to be distinct from the Golgi com- 
plex, but was enriched in the lysosomal membrane marker 
LGP 120, suggesting that it is involved in the formation of 
lysosomes. Furthermore, this late endosomal, prelysosomal 
compartment is significantly enriched in a tartrate-sensitive 
form of acid phosphatase. It represents the first acid phos- 
phatase-positive compartment in NRK cells encountered by 
newly endocytosed ligands on their way to lysosomes (Grif- 
fiths, G., manuscript in preparation). The coenrichment of 
tartrate-sensitive acid phosphatase  in  the  immunoisolated 
membranes is, therefore, consistent with this prelysosomal 
compartment being present in our purified preparations. The 
CI-MPR density of the prelysosomal compartment in bovine 
liver is probably much lower than that of NRK cells (26) 
since we did not observe the characteristic intense immuno- 
gold labeling seen in the cultured ceils. Although the exact 
relationship of CURL and the prelysosomal compartment is 
not clear, they do appear to be distinct compartments, and 
we have most likely enriched for components of both in our 
purified membranes. 
The finding that the CI-MPR and the CD-MPR are coen- 
riched in the same membranes is of particular significance, 
since it indicates that the two receptors do not sort lysosomal 
enzymes by entirely different  pathways. The membrane prep- 
arations isolated by antibodies specific for each receptor are 
not identical,  however.  When the  sucrose gradient pools 
were used as the  input fraction, the relative ratio of CI- 
MPR/CD-MPR adsorbed to the beads depended on the anti- 
body used. More CI-MPR was adsorbed to the anti-CI-MPR 
peptide beads, and more CD-MPR was adsorbed to the anti- 
CD-MPR peptide beads (Fig.  8 and Table  II).  Additional 
differences between the preparations were revealed by ana- 
lyzing the polypeptide compositions of the MPR-enriched 
membranes by SDS-PAGE. The relative levels of the 400- and 
170-kD bands are markedly different: the former appears to 
be primarily associated with the CI-MPR-enriched mem- 
branes while the latter is most apparent in the CD-MPR-en- 
riched membranes. There are two potential explanations for 
these differences. First, they could occur if small amounts 
of each of the two receptors are subsorted to distinct com- 
partments  (or  distinct regions of the  same compartment) 
which have different polypeptide compositions. This might 
indicate at least a partial functional difference between the 
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based on differences in the binding specificities of these two 
proteins (32,  33, 58) as well as the inability to detect CD- 
MPR-mediated  endocytosis  (56).  The alternative  explana- 
tion is that these differences reflect relative, rather than abso- 
lute, differences in the  steady-state  distribution of the two 
receptors.  For  instance,  one of the  preparations  could be 
more  enriched  in  early  endosomal  (CURL)  membranes, 
while the other might contain a relatively higher percentage 
of membranes derived from late endosomes (including the 
prelysosomal  compartment).  This  interpretation  would be 
consistent with both MPRs using the same endosomal/pre- 
lysosomal structures  for delivery of lysosomal enzymes to 
lysosomes  in bovine liver.  Further  characterization  of the 
purified membranes should clarify this issue, as well as pro- 
vide additional biochemical information on the basic mecha- 
nisms involved in MPR cycling and the segregation of acid 
hydrolases to lysosomes. 
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